Dana-Fiona Armour s A Tale of Symbiogenesis now on view in Stockholm artdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from artdaily.com Daily Mail and Mail on Sunday newspapers.
The First Art Newspaper on the Net., art daily,art news,artdaily, daily art, art, art newspaper, Museums, Exhibits, Artists, Milestones, Digital Art, Architecture, Photography, Photographers, Special Photos, Special Reports, Featured Stories, Auctions, Art Fairs, Anecdotes, Art Quiz, Education, Mythology, 360 Images, 3D Images, Last Week,, , , , ,
Exhibition of works by Dana-Fiona Armour on view at Collection Lambert artdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from artdaily.com Daily Mail and Mail on Sunday newspapers.
:
Key trends in the market include increasing research and development activities, increasing cases of influenza, ongoing clinical trials on plant-based vaccine, inorganic activities such as collaborations by the market players, and others.
Increasing number of research and development activities for improving the effectiveness of plant-based vaccines is expected to bolster growth of the plant-based vaccines market. For instance, on November 10, 2020, Medicago Inc. started conducting clinical trials for the production of plant-based COVID-19 vaccine. The company is planning to initiate Phase II/ III clinical trial after receiving positive results from the Phase I trial. Moreover, Medicago Inc. is also developing VLP Quadrivalent plant-based vaccine for Seasonal Influenza. Currently, the influenza vaccine is in Phase II of the clinical trial. In both the cases, Nicotiana Benthamiana, an Australian tobacco plant, is used for the production of COVID-19 and Influenza vaccine.